▶ 調査レポート

世界の水疱性類天疱瘡治療市場インサイト・予測(~2027年)

• 英文タイトル:Global Bullous Pemphigoid Therapies Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界の水疱性類天疱瘡治療市場インサイト・予測(~2027年) / Global Bullous Pemphigoid Therapies Market Insights and Forecast to 2027 / QYR2107PR102資料のイメージです。• レポートコード:QYR2107PR102
• 出版社/出版日:QYResearch / 2021年7月5日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、127ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は水疱性類天疱瘡治療の世界市場の現状について調査・分析し、2027年までの市場を予測しました。水疱性類天疱瘡治療の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(ステロイドクリーム、免疫抑制剤、抗生物質)、用途別市場規模(初期段階、積極的治療段階、削減段階、維持段階)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・水疱性類天疱瘡治療の世界市場概要
・メーカー別の競争状況、市場シェア
・水疱性類天疱瘡治療の種類別市場規模:ステロイドクリーム、免疫抑制剤、抗生物質
・水疱性類天疱瘡治療の用途別市場規模:初期段階、積極的治療段階、削減段階、維持段階
・北米の水疱性類天疱瘡治療市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの水疱性類天疱瘡治療市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの水疱性類天疱瘡治療市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の水疱性類天疱瘡治療市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの水疱性類天疱瘡治療市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Regeneron Pharmaceuticals、Sanofi、Pfizer、SUANFARMA、Tecoland Corporation、Century Pharmaceuticals、Akari Therapeutics、Immune Pharmaceuticals、Innate Pharma、AstraZeneca、Grifols、Aptalis、Medicis Pharmaceutical Corporation、Shaanxi Xiyue Pharmaceutical、Kunming Zhenhua Pharmaceutical Factory、Qinghai Pharmaceutical Factory
・水疱性類天疱瘡治療のバリューチェーン・販売チャネル分析
・水疱性類天疱瘡治療の世界市場動向

Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the West. Incidence figures are not available for most parts of the world but BP appears to be rarer in the Far East. Bullous pemphigoid is usually a disease of the elderly but it can also affect younger people and children. Both sexes are similarly affected.

Market Analysis and Insights: Global Bullous Pemphigoid Therapies Market
The global Bullous Pemphigoid Therapies market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Bullous Pemphigoid Therapies Scope and Segment
Bullous Pemphigoid Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bullous Pemphigoid Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Steroid Creams
Immune Suppressants
Antibiotics

Segment by Application
Initial Phase
Active Treatment Phase
Reducing Phase
Maintenance Phase

By Company
Regeneron Pharmaceuticals
Sanofi
Pfizer
SUANFARMA
Tecoland Corporation
Century Pharmaceuticals
Akari Therapeutics
Immune Pharmaceuticals
Innate Pharma
AstraZeneca
Grifols
Aptalis
Medicis Pharmaceutical Corporation
Shaanxi Xiyue Pharmaceutical
Kunming Zhenhua Pharmaceutical Factory
Qinghai Pharmaceutical Factory

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Bullous Pemphigoid Therapies Product Introduction
1.2 Market by Type
1.2.1 Global Bullous Pemphigoid Therapies Market Size Growth Rate by Type
1.2.2 Steroid Creams
1.2.3 Immune Suppressants
1.2.4 Antibiotics
1.3 Market by Application
1.3.1 Global Bullous Pemphigoid Therapies Market Size Growth Rate by Application
1.3.2 Initial Phase
1.3.3 Active Treatment Phase
1.3.4 Reducing Phase
1.3.5 Maintenance Phase
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Bullous Pemphigoid Therapies Sales Estimates and Forecasts 2016-2027
2.2 Global Bullous Pemphigoid Therapies Revenue Estimates and Forecasts 2016-2027
2.3 Global Bullous Pemphigoid Therapies Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Bullous Pemphigoid Therapies Regions by Sales
2.4.1 Global Top Bullous Pemphigoid Therapies Regions by Sales (2016-2021)
2.4.2 Global Top Bullous Pemphigoid Therapies Regions by Sales (2022-2027)
2.5 Global Top Bullous Pemphigoid Therapies Regions by Revenue
2.5.1 Global Top Bullous Pemphigoid Therapies Regions by Revenue (2016-2021)
2.5.2 Global Top Bullous Pemphigoid Therapies Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Bullous Pemphigoid Therapies Sales by Manufacturers
3.1.1 Global Top Bullous Pemphigoid Therapies Manufacturers by Sales (2016-2021)
3.1.2 Global Top Bullous Pemphigoid Therapies Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Bullous Pemphigoid Therapies Sales in 2020
3.2 Global Bullous Pemphigoid Therapies Revenue by Manufacturers
3.2.1 Global Top Bullous Pemphigoid Therapies Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Bullous Pemphigoid Therapies Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Bullous Pemphigoid Therapies Revenue in 2020
3.3 Global Bullous Pemphigoid Therapies Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bullous Pemphigoid Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bullous Pemphigoid Therapies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Bullous Pemphigoid Therapies Sales by Type
4.1.1 Global Bullous Pemphigoid Therapies Historical Sales by Type (2016-2021)
4.1.2 Global Bullous Pemphigoid Therapies Forecasted Sales by Type (2022-2027)
4.1.3 Global Bullous Pemphigoid Therapies Sales Market Share by Type (2016-2027)
4.2 Global Bullous Pemphigoid Therapies Revenue by Type
4.2.1 Global Bullous Pemphigoid Therapies Historical Revenue by Type (2016-2021)
4.2.2 Global Bullous Pemphigoid Therapies Forecasted Revenue by Type (2022-2027)
4.2.3 Global Bullous Pemphigoid Therapies Revenue Market Share by Type (2016-2027)
4.3 Global Bullous Pemphigoid Therapies Price by Type
4.3.1 Global Bullous Pemphigoid Therapies Price by Type (2016-2021)
4.3.2 Global Bullous Pemphigoid Therapies Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Bullous Pemphigoid Therapies Sales by Application
5.1.1 Global Bullous Pemphigoid Therapies Historical Sales by Application (2016-2021)
5.1.2 Global Bullous Pemphigoid Therapies Forecasted Sales by Application (2022-2027)
5.1.3 Global Bullous Pemphigoid Therapies Sales Market Share by Application (2016-2027)
5.2 Global Bullous Pemphigoid Therapies Revenue by Application
5.2.1 Global Bullous Pemphigoid Therapies Historical Revenue by Application (2016-2021)
5.2.2 Global Bullous Pemphigoid Therapies Forecasted Revenue by Application (2022-2027)
5.2.3 Global Bullous Pemphigoid Therapies Revenue Market Share by Application (2016-2027)
5.3 Global Bullous Pemphigoid Therapies Price by Application
5.3.1 Global Bullous Pemphigoid Therapies Price by Application (2016-2021)
5.3.2 Global Bullous Pemphigoid Therapies Price Forecast by Application (2022-2027)

6 North America
6.1 North America Bullous Pemphigoid Therapies Market Size by Type
6.1.1 North America Bullous Pemphigoid Therapies Sales by Type (2016-2027)
6.1.2 North America Bullous Pemphigoid Therapies Revenue by Type (2016-2027)
6.2 North America Bullous Pemphigoid Therapies Market Size by Application
6.2.1 North America Bullous Pemphigoid Therapies Sales by Application (2016-2027)
6.2.2 North America Bullous Pemphigoid Therapies Revenue by Application (2016-2027)
6.3 North America Bullous Pemphigoid Therapies Market Size by Country
6.3.1 North America Bullous Pemphigoid Therapies Sales by Country (2016-2027)
6.3.2 North America Bullous Pemphigoid Therapies Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Bullous Pemphigoid Therapies Market Size by Type
7.1.1 Europe Bullous Pemphigoid Therapies Sales by Type (2016-2027)
7.1.2 Europe Bullous Pemphigoid Therapies Revenue by Type (2016-2027)
7.2 Europe Bullous Pemphigoid Therapies Market Size by Application
7.2.1 Europe Bullous Pemphigoid Therapies Sales by Application (2016-2027)
7.2.2 Europe Bullous Pemphigoid Therapies Revenue by Application (2016-2027)
7.3 Europe Bullous Pemphigoid Therapies Market Size by Country
7.3.1 Europe Bullous Pemphigoid Therapies Sales by Country (2016-2027)
7.3.2 Europe Bullous Pemphigoid Therapies Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Bullous Pemphigoid Therapies Market Size by Type
8.1.1 Asia Pacific Bullous Pemphigoid Therapies Sales by Type (2016-2027)
8.1.2 Asia Pacific Bullous Pemphigoid Therapies Revenue by Type (2016-2027)
8.2 Asia Pacific Bullous Pemphigoid Therapies Market Size by Application
8.2.1 Asia Pacific Bullous Pemphigoid Therapies Sales by Application (2016-2027)
8.2.2 Asia Pacific Bullous Pemphigoid Therapies Revenue by Application (2016-2027)
8.3 Asia Pacific Bullous Pemphigoid Therapies Market Size by Region
8.3.1 Asia Pacific Bullous Pemphigoid Therapies Sales by Region (2016-2027)
8.3.2 Asia Pacific Bullous Pemphigoid Therapies Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Bullous Pemphigoid Therapies Market Size by Type
9.1.1 Latin America Bullous Pemphigoid Therapies Sales by Type (2016-2027)
9.1.2 Latin America Bullous Pemphigoid Therapies Revenue by Type (2016-2027)
9.2 Latin America Bullous Pemphigoid Therapies Market Size by Application
9.2.1 Latin America Bullous Pemphigoid Therapies Sales by Application (2016-2027)
9.2.2 Latin America Bullous Pemphigoid Therapies Revenue by Application (2016-2027)
9.3 Latin America Bullous Pemphigoid Therapies Market Size by Country
9.3.1 Latin America Bullous Pemphigoid Therapies Sales by Country (2016-2027)
9.3.2 Latin America Bullous Pemphigoid Therapies Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Bullous Pemphigoid Therapies Market Size by Type
10.1.1 Middle East and Africa Bullous Pemphigoid Therapies Sales by Type (2016-2027)
10.1.2 Middle East and Africa Bullous Pemphigoid Therapies Revenue by Type (2016-2027)
10.2 Middle East and Africa Bullous Pemphigoid Therapies Market Size by Application
10.2.1 Middle East and Africa Bullous Pemphigoid Therapies Sales by Application (2016-2027)
10.2.2 Middle East and Africa Bullous Pemphigoid Therapies Revenue by Application (2016-2027)
10.3 Middle East and Africa Bullous Pemphigoid Therapies Market Size by Country
10.3.1 Middle East and Africa Bullous Pemphigoid Therapies Sales by Country (2016-2027)
10.3.2 Middle East and Africa Bullous Pemphigoid Therapies Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Corporation Information
11.1.2 Regeneron Pharmaceuticals Overview
11.1.3 Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Product Description
11.1.5 Regeneron Pharmaceuticals Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Sanofi Bullous Pemphigoid Therapies Product Description
11.2.5 Sanofi Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Pfizer Bullous Pemphigoid Therapies Product Description
11.3.5 Pfizer Recent Developments
11.4 SUANFARMA
11.4.1 SUANFARMA Corporation Information
11.4.2 SUANFARMA Overview
11.4.3 SUANFARMA Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 SUANFARMA Bullous Pemphigoid Therapies Product Description
11.4.5 SUANFARMA Recent Developments
11.5 Tecoland Corporation
11.5.1 Tecoland Corporation Corporation Information
11.5.2 Tecoland Corporation Overview
11.5.3 Tecoland Corporation Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Tecoland Corporation Bullous Pemphigoid Therapies Product Description
11.5.5 Tecoland Corporation Recent Developments
11.6 Century Pharmaceuticals
11.6.1 Century Pharmaceuticals Corporation Information
11.6.2 Century Pharmaceuticals Overview
11.6.3 Century Pharmaceuticals Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Century Pharmaceuticals Bullous Pemphigoid Therapies Product Description
11.6.5 Century Pharmaceuticals Recent Developments
11.7 Akari Therapeutics
11.7.1 Akari Therapeutics Corporation Information
11.7.2 Akari Therapeutics Overview
11.7.3 Akari Therapeutics Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Akari Therapeutics Bullous Pemphigoid Therapies Product Description
11.7.5 Akari Therapeutics Recent Developments
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Corporation Information
11.8.2 Immune Pharmaceuticals Overview
11.8.3 Immune Pharmaceuticals Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Immune Pharmaceuticals Bullous Pemphigoid Therapies Product Description
11.8.5 Immune Pharmaceuticals Recent Developments
11.9 Innate Pharma
11.9.1 Innate Pharma Corporation Information
11.9.2 Innate Pharma Overview
11.9.3 Innate Pharma Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Innate Pharma Bullous Pemphigoid Therapies Product Description
11.9.5 Innate Pharma Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 AstraZeneca Bullous Pemphigoid Therapies Product Description
11.10.5 AstraZeneca Recent Developments
11.11 Grifols
11.11.1 Grifols Corporation Information
11.11.2 Grifols Overview
11.11.3 Grifols Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Grifols Bullous Pemphigoid Therapies Product Description
11.11.5 Grifols Recent Developments
11.12 Aptalis
11.12.1 Aptalis Corporation Information
11.12.2 Aptalis Overview
11.12.3 Aptalis Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Aptalis Bullous Pemphigoid Therapies Product Description
11.12.5 Aptalis Recent Developments
11.13 Medicis Pharmaceutical Corporation
11.13.1 Medicis Pharmaceutical Corporation Corporation Information
11.13.2 Medicis Pharmaceutical Corporation Overview
11.13.3 Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Product Description
11.13.5 Medicis Pharmaceutical Corporation Recent Developments
11.14 Shaanxi Xiyue Pharmaceutical
11.14.1 Shaanxi Xiyue Pharmaceutical Corporation Information
11.14.2 Shaanxi Xiyue Pharmaceutical Overview
11.14.3 Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Product Description
11.14.5 Shaanxi Xiyue Pharmaceutical Recent Developments
11.15 Kunming Zhenhua Pharmaceutical Factory
11.15.1 Kunming Zhenhua Pharmaceutical Factory Corporation Information
11.15.2 Kunming Zhenhua Pharmaceutical Factory Overview
11.15.3 Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Product Description
11.15.5 Kunming Zhenhua Pharmaceutical Factory Recent Developments
11.16 Qinghai Pharmaceutical Factory
11.16.1 Qinghai Pharmaceutical Factory Corporation Information
11.16.2 Qinghai Pharmaceutical Factory Overview
11.16.3 Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Product Description
11.16.5 Qinghai Pharmaceutical Factory Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Bullous Pemphigoid Therapies Value Chain Analysis
12.2 Bullous Pemphigoid Therapies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bullous Pemphigoid Therapies Production Mode & Process
12.4 Bullous Pemphigoid Therapies Sales and Marketing
12.4.1 Bullous Pemphigoid Therapies Sales Channels
12.4.2 Bullous Pemphigoid Therapies Distributors
12.5 Bullous Pemphigoid Therapies Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bullous Pemphigoid Therapies Industry Trends
13.2 Bullous Pemphigoid Therapies Market Drivers
13.3 Bullous Pemphigoid Therapies Market Challenges
13.4 Bullous Pemphigoid Therapies Market Restraints

14 Key Findings in The Global Bullous Pemphigoid Therapies Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Bullous Pemphigoid Therapies Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Steroid Creams
Table 3. Major Manufacturers of Immune Suppressants
Table 4. Major Manufacturers of Antibiotics
Table 5. Global Bullous Pemphigoid Therapies Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Bullous Pemphigoid Therapies Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Bullous Pemphigoid Therapies Sales by Region (2016-2021) & (Units)
Table 8. Global Bullous Pemphigoid Therapies Sales Market Share by Region (2016-2021)
Table 9. Global Bullous Pemphigoid Therapies Sales by Region (2022-2027) & (Units)
Table 10. Global Bullous Pemphigoid Therapies Sales Market Share by Region (2022-2027)
Table 11. Global Bullous Pemphigoid Therapies Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Bullous Pemphigoid Therapies Revenue Market Share by Region (2016-2021)
Table 13. Global Bullous Pemphigoid Therapies Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Bullous Pemphigoid Therapies Revenue Market Share by Region (2022-2027)
Table 15. Global Bullous Pemphigoid Therapies Sales by Manufacturers (2016-2021) & (Units)
Table 16. Global Bullous Pemphigoid Therapies Sales Share by Manufacturers (2016-2021)
Table 17. Global Bullous Pemphigoid Therapies Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Bullous Pemphigoid Therapies Revenue Share by Manufacturers (2016-2021)
Table 19. Bullous Pemphigoid Therapies Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Bullous Pemphigoid Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Bullous Pemphigoid Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bullous Pemphigoid Therapies as of 2020)
Table 22. Bullous Pemphigoid Therapies Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Bullous Pemphigoid Therapies Product Offered
Table 24. Date of Manufacturers Enter into Bullous Pemphigoid Therapies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bullous Pemphigoid Therapies Sales by Type (2016-2021) & (Units)
Table 27. Global Bullous Pemphigoid Therapies Sales by Type (2022-2027) & (Units)
Table 28. Global Bullous Pemphigoid Therapies Sales Share by Type (2016-2021)
Table 29. Global Bullous Pemphigoid Therapies Sales Share by Type (2022-2027)
Table 30. Global Bullous Pemphigoid Therapies Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Bullous Pemphigoid Therapies Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Bullous Pemphigoid Therapies Revenue Share by Type (2016-2021)
Table 33. Global Bullous Pemphigoid Therapies Revenue Share by Type (2022-2027)
Table 34. Bullous Pemphigoid Therapies Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Bullous Pemphigoid Therapies Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Bullous Pemphigoid Therapies Sales by Application (2016-2021) & (Units)
Table 37. Global Bullous Pemphigoid Therapies Sales by Application (2022-2027) & (Units)
Table 38. Global Bullous Pemphigoid Therapies Sales Share by Application (2016-2021)
Table 39. Global Bullous Pemphigoid Therapies Sales Share by Application (2022-2027)
Table 40. Global Bullous Pemphigoid Therapies Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Bullous Pemphigoid Therapies Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Bullous Pemphigoid Therapies Revenue Share by Application (2016-2021)
Table 43. Global Bullous Pemphigoid Therapies Revenue Share by Application (2022-2027)
Table 44. Bullous Pemphigoid Therapies Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Bullous Pemphigoid Therapies Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Bullous Pemphigoid Therapies Sales by Type (2016-2021) & (Units)
Table 47. North America Bullous Pemphigoid Therapies Sales by Type (2022-2027) & (Units)
Table 48. North America Bullous Pemphigoid Therapies Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Bullous Pemphigoid Therapies Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Bullous Pemphigoid Therapies Sales by Application (2016-2021) & (Units)
Table 51. North America Bullous Pemphigoid Therapies Sales by Application (2022-2027) & (Units)
Table 52. North America Bullous Pemphigoid Therapies Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Bullous Pemphigoid Therapies Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Bullous Pemphigoid Therapies Sales by Country (2016-2021) & (Units)
Table 55. North America Bullous Pemphigoid Therapies Sales by Country (2022-2027) & (Units)
Table 56. North America Bullous Pemphigoid Therapies Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Bullous Pemphigoid Therapies Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Bullous Pemphigoid Therapies Sales by Type (2016-2021) & (Units)
Table 59. Europe Bullous Pemphigoid Therapies Sales by Type (2022-2027) & (Units)
Table 60. Europe Bullous Pemphigoid Therapies Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Bullous Pemphigoid Therapies Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Bullous Pemphigoid Therapies Sales by Application (2016-2021) & (Units)
Table 63. Europe Bullous Pemphigoid Therapies Sales by Application (2022-2027) & (Units)
Table 64. Europe Bullous Pemphigoid Therapies Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Bullous Pemphigoid Therapies Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Bullous Pemphigoid Therapies Sales by Country (2016-2021) & (Units)
Table 67. Europe Bullous Pemphigoid Therapies Sales by Country (2022-2027) & (Units)
Table 68. Europe Bullous Pemphigoid Therapies Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Bullous Pemphigoid Therapies Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Bullous Pemphigoid Therapies Sales by Type (2016-2021) & (Units)
Table 71. Asia Pacific Bullous Pemphigoid Therapies Sales by Type (2022-2027) & (Units)
Table 72. Asia Pacific Bullous Pemphigoid Therapies Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Bullous Pemphigoid Therapies Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Bullous Pemphigoid Therapies Sales by Application (2016-2021) & (Units)
Table 75. Asia Pacific Bullous Pemphigoid Therapies Sales by Application (2022-2027) & (Units)
Table 76. Asia Pacific Bullous Pemphigoid Therapies Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Bullous Pemphigoid Therapies Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Bullous Pemphigoid Therapies Sales by Region (2016-2021) & (Units)
Table 79. Asia Pacific Bullous Pemphigoid Therapies Sales by Region (2022-2027) & (Units)
Table 80. Asia Pacific Bullous Pemphigoid Therapies Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Bullous Pemphigoid Therapies Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Bullous Pemphigoid Therapies Sales by Type (2016-2021) & (Units)
Table 83. Latin America Bullous Pemphigoid Therapies Sales by Type (2022-2027) & (Units)
Table 84. Latin America Bullous Pemphigoid Therapies Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Bullous Pemphigoid Therapies Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Bullous Pemphigoid Therapies Sales by Application (2016-2021) & (Units)
Table 87. Latin America Bullous Pemphigoid Therapies Sales by Application (2022-2027) & (Units)
Table 88. Latin America Bullous Pemphigoid Therapies Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Bullous Pemphigoid Therapies Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Bullous Pemphigoid Therapies Sales by Country (2016-2021) & (Units)
Table 91. Latin America Bullous Pemphigoid Therapies Sales by Country (2022-2027) & (Units)
Table 92. Latin America Bullous Pemphigoid Therapies Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Bullous Pemphigoid Therapies Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Bullous Pemphigoid Therapies Sales by Type (2016-2021) & (Units)
Table 95. Middle East and Africa Bullous Pemphigoid Therapies Sales by Type (2022-2027) & (Units)
Table 96. Middle East and Africa Bullous Pemphigoid Therapies Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Bullous Pemphigoid Therapies Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Bullous Pemphigoid Therapies Sales by Application (2016-2021) & (Units)
Table 99. Middle East and Africa Bullous Pemphigoid Therapies Sales by Application (2022-2027) & (Units)
Table 100. Middle East and Africa Bullous Pemphigoid Therapies Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Bullous Pemphigoid Therapies Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Bullous Pemphigoid Therapies Sales by Country (2016-2021) & (Units)
Table 103. Middle East and Africa Bullous Pemphigoid Therapies Sales by Country (2022-2027) & (Units)
Table 104. Middle East and Africa Bullous Pemphigoid Therapies Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Bullous Pemphigoid Therapies Revenue by Country (2022-2027) & (US$ Million)
Table 106. Regeneron Pharmaceuticals Corporation Information
Table 107. Regeneron Pharmaceuticals Description and Major Businesses
Table 108. Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Regeneron Pharmaceuticals Bullous Pemphigoid Therapies Product
Table 110. Regeneron Pharmaceuticals Recent Developments
Table 111. Sanofi Corporation Information
Table 112. Sanofi Description and Major Businesses
Table 113. Sanofi Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Sanofi Bullous Pemphigoid Therapies Product
Table 115. Sanofi Recent Developments
Table 116. Pfizer Corporation Information
Table 117. Pfizer Description and Major Businesses
Table 118. Pfizer Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Pfizer Bullous Pemphigoid Therapies Product
Table 120. Pfizer Recent Developments
Table 121. SUANFARMA Corporation Information
Table 122. SUANFARMA Description and Major Businesses
Table 123. SUANFARMA Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. SUANFARMA Bullous Pemphigoid Therapies Product
Table 125. SUANFARMA Recent Developments
Table 126. Tecoland Corporation Corporation Information
Table 127. Tecoland Corporation Description and Major Businesses
Table 128. Tecoland Corporation Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Tecoland Corporation Bullous Pemphigoid Therapies Product
Table 130. Tecoland Corporation Recent Developments
Table 131. Century Pharmaceuticals Corporation Information
Table 132. Century Pharmaceuticals Description and Major Businesses
Table 133. Century Pharmaceuticals Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Century Pharmaceuticals Bullous Pemphigoid Therapies Product
Table 135. Century Pharmaceuticals Recent Developments
Table 136. Akari Therapeutics Corporation Information
Table 137. Akari Therapeutics Description and Major Businesses
Table 138. Akari Therapeutics Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Akari Therapeutics Bullous Pemphigoid Therapies Product
Table 140. Akari Therapeutics Recent Developments
Table 141. Immune Pharmaceuticals Corporation Information
Table 142. Immune Pharmaceuticals Description and Major Businesses
Table 143. Immune Pharmaceuticals Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Immune Pharmaceuticals Bullous Pemphigoid Therapies Product
Table 145. Immune Pharmaceuticals Recent Developments
Table 146. Innate Pharma Corporation Information
Table 147. Innate Pharma Description and Major Businesses
Table 148. Innate Pharma Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Innate Pharma Bullous Pemphigoid Therapies Product
Table 150. Innate Pharma Recent Developments
Table 151. AstraZeneca Corporation Information
Table 152. AstraZeneca Description and Major Businesses
Table 153. AstraZeneca Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. AstraZeneca Bullous Pemphigoid Therapies Product
Table 155. AstraZeneca Recent Developments
Table 156. Grifols Corporation Information
Table 157. Grifols Description and Major Businesses
Table 158. Grifols Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. Grifols Bullous Pemphigoid Therapies Product
Table 160. Grifols Recent Developments
Table 161. Aptalis Corporation Information
Table 162. Aptalis Description and Major Businesses
Table 163. Aptalis Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 164. Aptalis Bullous Pemphigoid Therapies Product
Table 165. Aptalis Recent Developments
Table 166. Medicis Pharmaceutical Corporation Corporation Information
Table 167. Medicis Pharmaceutical Corporation Description and Major Businesses
Table 168. Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 169. Medicis Pharmaceutical Corporation Bullous Pemphigoid Therapies Product
Table 170. Medicis Pharmaceutical Corporation Recent Developments
Table 171. Shaanxi Xiyue Pharmaceutical Corporation Information
Table 172. Shaanxi Xiyue Pharmaceutical Description and Major Businesses
Table 173. Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 174. Shaanxi Xiyue Pharmaceutical Bullous Pemphigoid Therapies Product
Table 175. Shaanxi Xiyue Pharmaceutical Recent Developments
Table 176. Kunming Zhenhua Pharmaceutical Factory Corporation Information
Table 177. Kunming Zhenhua Pharmaceutical Factory Description and Major Businesses
Table 178. Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 179. Kunming Zhenhua Pharmaceutical Factory Bullous Pemphigoid Therapies Product
Table 180. Kunming Zhenhua Pharmaceutical Factory Recent Developments
Table 181. Qinghai Pharmaceutical Factory Corporation Information
Table 182. Qinghai Pharmaceutical Factory Description and Major Businesses
Table 183. Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 184. Qinghai Pharmaceutical Factory Bullous Pemphigoid Therapies Product
Table 185. Qinghai Pharmaceutical Factory Recent Developments
Table 186. Key Raw Materials Lists
Table 187. Raw Materials Key Suppliers Lists
Table 188. Bullous Pemphigoid Therapies Distributors List
Table 189. Bullous Pemphigoid Therapies Customers List
Table 190. Bullous Pemphigoid Therapies Market Trends
Table 191. Bullous Pemphigoid Therapies Market Drivers
Table 192. Bullous Pemphigoid Therapies Market Challenges
Table 193. Bullous Pemphigoid Therapies Market Restraints
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Bullous Pemphigoid Therapies Product Picture
Figure 2. Global Bullous Pemphigoid Therapies Market Share by Type in 2020 & 2027
Figure 3. Steroid Creams Product Picture
Figure 4. Immune Suppressants Product Picture
Figure 5. Antibiotics Product Picture
Figure 6. Global Bullous Pemphigoid Therapies Market Share by Application in 2020 & 2027
Figure 7. Initial Phase
Figure 8. Active Treatment Phase
Figure 9. Reducing Phase
Figure 10. Maintenance Phase
Figure 11. Bullous Pemphigoid Therapies Report Years Considered
Figure 12. Global Bullous Pemphigoid Therapies Sales 2016-2027 (Units)
Figure 13. Global Bullous Pemphigoid Therapies Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bullous Pemphigoid Therapies Revenue 2016-2027 (US$ Million)
Figure 15. Global Bullous Pemphigoid Therapies Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Bullous Pemphigoid Therapies Sales Market Share by Region (2016-2021)
Figure 17. Global Bullous Pemphigoid Therapies Sales Market Share by Region (2022-2027)
Figure 18. North America Bullous Pemphigoid Therapies Sales YoY (2016-2027) & (Units)
Figure 19. North America Bullous Pemphigoid Therapies Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Bullous Pemphigoid Therapies Sales YoY (2016-2027) & (Units)
Figure 21. Europe Bullous Pemphigoid Therapies Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Bullous Pemphigoid Therapies Sales YoY (2016-2027) & (Units)
Figure 23. Asia-Pacific Bullous Pemphigoid Therapies Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Bullous Pemphigoid Therapies Sales YoY (2016-2027) & (Units)
Figure 25. Latin America Bullous Pemphigoid Therapies Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Bullous Pemphigoid Therapies Sales YoY (2016-2027) & (Units)
Figure 27. Middle East & Africa Bullous Pemphigoid Therapies Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Bullous Pemphigoid Therapies Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Bullous Pemphigoid Therapies Revenue in 2020
Figure 30. Bullous Pemphigoid Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Bullous Pemphigoid Therapies Sales Market Share by Type (2016-2027)
Figure 32. Global Bullous Pemphigoid Therapies Revenue Market Share by Type (2016-2027)
Figure 33. Global Bullous Pemphigoid Therapies Sales Market Share by Application (2016-2027)
Figure 34. Global Bullous Pemphigoid Therapies Revenue Market Share by Application (2016-2027)
Figure 35. North America Bullous Pemphigoid Therapies Sales Market Share by Type (2016-2027)
Figure 36. North America Bullous Pemphigoid Therapies Revenue Market Share by Type (2016-2027)
Figure 37. North America Bullous Pemphigoid Therapies Sales Market Share by Application (2016-2027)
Figure 38. North America Bullous Pemphigoid Therapies Revenue Market Share by Application (2016-2027)
Figure 39. North America Bullous Pemphigoid Therapies Sales Share by Country (2016-2027)
Figure 40. North America Bullous Pemphigoid Therapies Revenue Share by Country (2016-2027)
Figure 41. United States Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Bullous Pemphigoid Therapies Sales Market Share by Type (2016-2027)
Figure 44. Europe Bullous Pemphigoid Therapies Revenue Market Share by Type (2016-2027)
Figure 45. Europe Bullous Pemphigoid Therapies Sales Market Share by Application (2016-2027)
Figure 46. Europe Bullous Pemphigoid Therapies Revenue Market Share by Application (2016-2027)
Figure 47. Europe Bullous Pemphigoid Therapies Sales Share by Country (2016-2027)
Figure 48. Europe Bullous Pemphigoid Therapies Revenue Share by Country (2016-2027)
Figure 49. Germany Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 50. France Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Bullous Pemphigoid Therapies Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Bullous Pemphigoid Therapies Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Bullous Pemphigoid Therapies Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Bullous Pemphigoid Therapies Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Bullous Pemphigoid Therapies Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Bullous Pemphigoid Therapies Revenue Share by Region (2016-2027)
Figure 60. China Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 63. India Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 64. Australia Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 65. China Taiwan Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 66. Indonesia Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 67. Thailand Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 68. Malaysia Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Bullous Pemphigoid Therapies Sales Market Share by Type (2016-2027)
Figure 70. Latin America Bullous Pemphigoid Therapies Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Bullous Pemphigoid Therapies Sales Market Share by Application (2016-2027)
Figure 72. Latin America Bullous Pemphigoid Therapies Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Bullous Pemphigoid Therapies Sales Share by Country (2016-2027)
Figure 74. Latin America Bullous Pemphigoid Therapies Revenue Share by Country (2016-2027)
Figure 75. Mexico Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Bullous Pemphigoid Therapies Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Bullous Pemphigoid Therapies Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Bullous Pemphigoid Therapies Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Bullous Pemphigoid Therapies Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Bullous Pemphigoid Therapies Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Bullous Pemphigoid Therapies Revenue Share by Country (2016-2027)
Figure 84. Turkey Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 86. UAE Bullous Pemphigoid Therapies Revenue (2016-2027) & (US$ Million)
Figure 87. Bullous Pemphigoid Therapies Value Chain
Figure 88. Bullous Pemphigoid Therapies Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed